Interview with Ken Duncan on COVID-19 (novel coronavirus). Duncan leads drug discovery efforts for the Bill & Melinda Gates Foundation's Discovery & Translational Sciences team.
We are joining forces with Wellcome and Mastercard to beef up our COVID-19 response—backed by $125 million in both new funding and money already earmarked to tackle this epidemic. The expertise of pharmaceutical companies will be critical to this endeavor, named the COVID-19 Therapeutics Accelerator
Sign up for The Optimist newsletter
Subscribe to The Optimist to get weekly updates on the latest in global health, gender equality, education, and more.